XML 44 R33.htm IDEA: XBRL DOCUMENT
v3.19.1

Stockholders' Equity (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2019
Equity [Abstract] |
Schedule of Preferred Stock and the Accretion Of Dividends Activity | The following table summarizes Series B Preferred Stock and the accretion of dividends activity for the three months ended March 31, 2019 (in thousands):
|  | Tranche 1 |  |  | Tranche 2 |  |  | Total |
Series B Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |
Balance at December 31, 2018 |  | $ | 12,600 |  |  | $ | 8,233 |  |  | $ | 20,833 |
Cumulative dividends on Series B preferred stock |  |  | 158 |  |  |  | 100 |  |  |  | 258 |
Balance at March 31, 2019 |  | $ | 12,758 |  |  | $ | 8,333 |  |  | $ | 21,091 |
Number of Common Shares Issuable Upon Conversion |  |  |  |  |  |  |  |  |  |  |  |
Balance at December 31, 2018 |  |  | 3,150 |  |  |  | 2,058 |  |  |  | 5,208 |
Cumulative dividends on Series B preferred stock |  |  | 39 |  |  |  | 25 |  |  |  | 64 |
Balance at March 31, 2019 |  |  | 3,189 |  |  |  | 2,083 |  |  |  | 5,272 |
Summary of Outstanding Warrants Issued by Company | Below is the summary of outstanding warrants issued by the Company as of March 31, 2019:
Warrant Type |  | Number of Shares Issuable Upon Exercise |  |  | Weighted Average Exercise Price |  |  | Issue Date |  | Expiration Date
2014 Consultant Warrant |  |  | 85,000 |  |  | $ | 10.70 |  |  | August 13, 2014 |  | August 13, 2019
East West Bank Warrant |  |  | 40,000 |  |  |  | 3.64 |  |  | February 8, 2017 |  | February 8, 2022
VLL7 and VLL8 Warrants |  |  | 580,000 |  |  |  | 2.00 |  |  | February 8, 2017 |  | February 8, 2022
Total |  |  | 705,000 |  |  |  |  |  |  |  |  |
Schedule of Common Stock Reserved for Future Issuance | Common Stock Reserved for Future Issuance Common stock reserved for future issuance as of March 31, 2019 was as follows:
Exercise of outstanding stock options, vesting of restricted stock units ("RSU"), and issuance of RSUs vested but not released |  |  | 2,431,800 |
ESPP |  |  | 293,888 |
Shares of common stock available for grant under the 2011 Plan |  |  | 523,037 |
Noncontrolling interest in Bluehill ID AG |  |  | 10,355 |
Warrants to purchase common stock |  |  | 705,000 |
Shares of common stock issuable upon conversion of Series B preferred stock |  |  | 7,541,449 |
Total |  |  | 11,505,529 |

X
- Definition Schedule of common stock reserved for future issuance. + References No definition available. + Details
Name: | inve_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
Namespace Prefix: | inve_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of preferred stock and the accretion of dividends activity. + References No definition available. + Details
Name: | inve_ScheduleOfPreferredStockAndTheAccretionOfDividendsActivityTableTextBlock
Namespace Prefix: | inve_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration